EXPLORE MORE CATEGORIES
- Home
- ยป
- Our Products
- »
- Antidiabetic Drug
Antidiabetic Drug
Our product range includes a wide range of insulin delivery device, humapen ergo 2, empagliflozin 10 mg tablets, acarbose 25mg tablets, semaglutide injection 0.25mg and saroglitazar tablets 4mg.
Insulin Delivery Device
Get Latest Price
Product Brochure
Product Details:
| Pen Type | Disposable Pen |
| Cartridge Size | 3 ml |
| Compatible Insulin | insulin delivery device |
| Brand | BASUGINE PEN |
| Usage | Type 1 Diabetes, Type 2 Diabetes |
| Colour | Blue |
| Packaging Type | Single Pen |
Insulin Delivery Device is a medical device designed to safely and accurately administer insulin to individuals with diabetes. It allows controlled delivery of insulin into the body, helping maintain proper blood glucose levels as prescribed by a healthcare professional.
Insulin delivery devices are typically used for subcutaneous injection and are engineered for ease of use, dosing accuracy, and patient comfort. Common types include insulin pens, syringes, and insulin pumps, with pen devices being widely used due to their convenience and portability.
Yes! I am InterestedRequest A Callback
Humapen Ergo 2
Get Latest Price
Product Brochure
Product Details:
| Pen Type | Reusable Pen |
| Cartridge Size | 3 ml |
| Compatible Insulin | Human Insulin |
| Brand | Humapen |
Human Pen Ergo 2 is a reusable insulin delivery device designed for the accurate and convenient administration of insulin cartridges for people with diabetes. It is ergonomically designed to provide comfortable handling, ease of use, and precise dose delivery, making it suitable for daily insulin therapy.
The device allows subcutaneous injection of insulin and is compatible with standard insulin cartridges, enabling patients to replace cartridges without changing the pen. Human Pen Ergo 2 features a clear dose display, smooth dose-setting mechanism, and reliable injection performance to support accurate dosing.
Yes! I am InterestedRequest A Callback
Empagliflozin 10 Mg Tablets
Get Latest Price
Product Brochure
Product Details:
| Strength | 10 mg |
| Composition | Empagliflozin |
| Pack Size | 10 tablets |
| Brand | Jardiance |
| Usage | Type 2 Diabetes |
| Shelf Life | 36 months |
Yes! I am InterestedRequest A Callback
Acarbose 25mg Tablets
Product Price: Rs 155 / BoxGet Best Price
Minimum Order Quantity: 200 Box
Product Brochure
Product Details:
| Strength | 25 mg |
| Composition | Acarbose |
| Form | Tablets |
| Pack Size | 10 tablets |
| Usage | To Treat Type 2 Diabetes |
| Packaging Size | 30 Tablets |
| Brand | Hibose 25 |
| Manufacturer | Healing |
| Prescription/Non prescription | Prescription |
| Packaging Type | Box |
Yes! I am InterestedRequest A Callback
Semaglutide Injection 0.25mg
Get Latest Price
Product Brochure
Product Details:
| Strength | 0.25 mg |
| Pack Type | Prefilled Pen |
| Volume | 1.5 ml |
| Brand | Poviztra |
| Usage | Type 2 Diabetes, Weight Loss |
| Injection Route | SC |
| Shelf Life | 24 months |
Semaglutide Injection 0.25 mg is a prescription medication used as an initial starting dose to help the body adjust to semaglutide therapy. It belongs to the class of drugs known as GLP-1 receptor agonists, which work by mimicking a natural hormone that regulates blood sugar levels and appetite.
This medication is administered as a once-weekly subcutaneous injection and is commonly prescribed for adults with type 2 diabetes or as part of a weight management program, depending on the brand and medical indication. The 0.25 mg dose is not intended to provide full therapeutic effect but is used to reduce gastrointestinal side effects before increasing to higher maintenance doses.
Yes! I am InterestedRequest A Callback
Saroglitazar Tablets 4mg
Get Latest Price
Product Brochure
Product Details:
| Dose | 4 mg |
| Brand | Lipaglyn |
| Manufacturer | Zydus |
| Composition | Saroglitazar |
| Treatment | Hypertriglyceridemia |
| Pack Size | 10 tablets |
| Packaging Type | Strip |
| Shelf Life | 36 months |
| Product Type | Tablet |
Saroglitazar Tablets 4 mg are used in the management of dyslipidemia, particularly in patients with diabetic dyslipidemia and hypertriglyceridemia. Saroglitazar is a dual peroxisome proliferator-activated receptor (PPAR) α/γ agonist that helps regulate lipid and glucose metabolism. By reducing triglyceride levels, lowering LDL cholesterol, increasing HDL cholesterol, and improving insulin sensitivity, Saroglitazar supports better metabolic control and helps reduce cardiovascular risk in patients with type 2 diabetes and related lipid disorders.
Yes! I am InterestedRequest A Callback